Iniciar Sesión Regístrate abrir menu

Bibliografía Científica

Artículos por temáticas

En este apartado encontrará una actualización mensual de Enfermedad de Alzheimer y Demencias

1708 ARTÍCULOS , VIENDO DEL 961 AL 975

Validation of orthopaedic surgeons' assessment of cognitive function in patients with acute hip fracture

Kristoffersen MH, Dybvik E, Steihaug OM, Bartz-Johannesen CA, Martinsen MI, Ranhoff AH, Engesæter LB, Gjertsen JE.

BMC Musculoskelet Disord. 2019 Jun 1;20(1):268. doi: 10.1186/s12891-019-2633-x.

Population-Based Approaches to Dementia Prevention

Sexton CE, Yaffe K.

J Alzheimers Dis. 2019;70(s1):S15-S17. doi: 10.3233/JAD-190104.

Neuropsychological Similarities and Differences Between Amnestic Alzheimer's Disease and its Non-Amnestic Variants

Mendez MF, Monserratt LH, Liang LJ, Chavez D, Jimenez EE, Maurer JJ, Laffey M.

J Alzheimers Dis. 2019;69(3):849-855. doi: 10.3233/JAD-190124.

Association of Alzheimer's Disease Genetic Risk Loci with Cognitive Performance and Decline: A Systematic Review

Andrews SJ, McFall GP, Booth A, Dixon RA, Anstey KJ.

J Alzheimers Dis. 2019;69(4):1109-1136. doi: 10.3233/JAD-190342.

Endo-lysosomal dysregulations and late-onset Alzheimer's disease: impact of genetic risk factors

Van Acker ZP, Bretou M, Annaert W.

Mol Neurodegener. 2019 Jun 3;14(1):20. doi: 10.1186/s13024-019-0323-7.

Functional Neural Correlates of Anosognosia in Mild Cognitive Impairment and Alzheimer's Disease: a Systematic Review

Mondragón JD, Maurits NM, De Deyn PP.

Neuropsychol Rev. 2019 Jun;29(2):139-165. doi: 10.1007/s11065-019-09410-x. Epub 2019 Jun 3.

The efficacy and underlying mechanism of phosphodiesterase- 5 inhibitors in preventing cognitive impairment and Alzheimer pathology: A systematic review of animal studies

El-Bakly W, Wagdy O, Sobhy A, Abo Elenain O, Riad MS, El Sayed M, Tarkhan S, Yassen M, Mahmoud A, Bassiony M, Nabil N.

Behav Brain Res. 2019 Oct 17;372:112004. doi: 10.1016/j.bbr.2019.112004. Epub 2019 Jun 1.

Subthreshold amyloid and its biological and clinical meaning: Long way ahead

Bischof GN, Jacobs HIL.

Neurology. 2019 Jul 9;93(2):72-79. doi: 10.1212/WNL.0000000000007747. Epub 2019 Jun 5.

Neurocognitive Phenotyping of HIV in the Era of Antiretroviral Therapy

Paul R.

Curr HIV/AIDS Rep. 2019 Jun;16(3):230-235. doi: 10.1007/s11904-019-00426-9.

[Clinically relevant late-life depression as risk factor of dementia: a systematic review and meta-analysis of prospective cohort studies]

Santabarbara J, Sevil-Perez A, Olaya B, Gracia-Garcia P, Lopez-Anton R.

Rev Neurol. 2019 Jun 16;68(12):493-502. doi: 10.33588/rn.6812.2018398.

Measuring gait speed to better identify prodromal dementia

Grande G, Triolo F, Nuara A, Welmer AK, Fratiglioni L, Vetrano DL.

Exp Gerontol. 2019 Sep;124:110625. doi: 10.1016/j.exger.2019.05.014. Epub 2019 Jun 4.

Retinal Microvascular and Neurodegenerative Changes in Alzheimer's Disease and Mild Cognitive Impairment Compared with Control Participants

Yoon SP, Grewal DS, Thompson AC, Polascik BW, Dunn C, Burke JR, Fekrat S.

Ophthalmol Retina. 2019 Jun;3(6):489-499. doi: 10.1016/j.oret.2019.02.002. Epub 2019 Mar 11.

Apolipoprotein E4, inhibitory network dysfunction, and Alzheimer's disease

Najm R, Jones EA, Huang Y.

Mol Neurodegener. 2019 Jun 11;14(1):24. doi: 10.1186/s13024-019-0324-6.

The ever expanding issue of later life mental health

Glynn K, Lyne J.

Ir J Psychol Med. 2019 Jun;36(2):83-84. doi: 10.1017/ipm.2019.21.

Actualización mensual Regístrese para recibir los avisos de actualización

Si quiere recomendar un artículo/publicación para completar este apartado puede hacerlo a través del formulario de contacto para su valoración.

En ningún caso la información facilitada constituye asesoramiento por parte de Zambon

Con el aval de:

Logo SEN Logo WIS

En colaboración con:

Zambon Neurociencias